Andreotti, Felicita

Andreotti, Felicita

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Dettaglio

Andreotti, Felicita 

ROMA - Dipartimento di Scienze cardiovascolari e pneumologiche 

Pubblicazioni

Risultati 1 - 20 di 102 (tempo di esecuzione: 0.001 secondi).

Data di pubblicazioneTitoloAutore(i)File
12020Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysisGalli, M.; Andreotti, F.; D'Amario, D.; Vergallo, R.; Vescovo, G. M.; Giraldi, L.; Migliaro, S.; Ameri, P.; Porto, I.; Crea, F.-
22021From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19Vinci, R.; Pedicino, D.; Andreotti, F.; Russo, G.; D'Aiello, A.; De Cristofaro, R.; Crea, F.; Liuzzo, G.-
32021Doppler Ultrasound Monitoring of Echogenicity in Asymptomatic Subcritical Carotid Stenosis and Assessment of Response to Oral Supplementation of Vitamin K2 (PLAK2 Randomized Controlled Trial)Tshomba, Yamume; Baccellieri, Domenico; Carta, Niccolò; Cilli, Giuseppe; Ardita, Vincenzo; Apruzzi, Luca; Loschi, Diletta; Kahlberg, Andrea; Bertoglio, Luca; Castellano, Renata; Simonini, Elisa; Andreotti, Felicita; Chiesa, Roberto-
42021Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men with Atrial Fibrillation in the ENGAGE AF-TIMI 48 TrialZelniker, T. A.; Ardissino, M.; Andreotti, F.; O'Donoghue, M. L.; Yin, O.; Park, J. -G.; Murphy, S. A.; Ruff, C. T.; Lanz, H. J.; Antman, E. M.; Braunwald, E.; Giugliano, R. P.; Merlini, P. A.-
52021Aims: The ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation (ORIGAMI) study investigates the safety and efficacy of Edoxaban administered via PEG in patients with atrial fibrillation and a clinical indication for a long-term anticoagulation. Design: In this prospective, single-centre observational study, 12 PEG-treated patients with indication to anticoagulation will receive edoxaban via PEG and will be followed up to 6 months. Plasma antifactor Xa activity and edoxaban concentrations will be assessed. Thromboembolic (ischaemic stroke, systemic embolism, venous thromboembolism) and bleeding events (Bleeding Academic Research Consortium and Thrombolysis in Myocardial Infarction) will be recorded at 1 and 6 months. Preliminary results: A retrospective analysis of five atrial fibrillation cases undergoing PEG implantation at our Institution who received edoxaban via PEG showed plasma anti-FXa levels at a steady state of 146 ± 15 ng/ml, without major adverse event at a mean follow-up of 6 months. Conclusion: ORIGAMI prospectively investigates PEG-administration of edoxaban in PEG-treated patients requiring long-term anticoagulation. Our preliminary retrospective data support this route of DOAC administration.1, Domenico D'Amario; Galli, Mattia; Canonico, Francesco; Restivo, Attilio; Arcudi, Alessandra; Scacciavillani, Roberto; Cappannoli, Luigi; Riccioni, Maria Elena; Giuseppina Annetta, Maria; Di Stefano, Gaetano; Piccinni, Carlo; Vergallo, Rocco; Antonio Montone, Rocco; Maria Leone, Antonio; Niccoli, Giampaolo; Sabatelli, Mario; Antonelli, Massimo; Andreotti, Felicita; De Cristofaro, Raimondo; Crea, Filippo-
62021ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) studyD'Amario, D.; Galli, M.; Canonico, F.; Restivo, A.; Arcudi, A.; Scacciavillani, R.; Cappannoli, L.; Riccioni, M. E.; Annetta, M. G.; Di Stefano, G.; Piccinni, C.; Vergallo, R.; Montone, R. A.; Leone, A. M.; Niccoli, G.; Sabatelli, M.; Antonelli, M.; Andreotti, F.; De Cristofaro, R.; Crea, F.-
72021Family history in first degree relatives of patients with premature cardiovascular diseaseAndreotti, F.; Crea, F.; Patti, G.; Shoulders, C. C.; Navarese, E. P.; Robishaw, J.; Maseri, A.; Hennekens, C. H.-
82020ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study1, Domenico D'Amario; Galli, Mattia; Canonico, Francesco; Restivo, Attilio; Arcudi, Alessandra; Scacciavillani, Roberto; Cappannoli, Luigi; Riccioni, Maria Elena; Annetta, Maria Giuseppina; Di Stefano, Gaetano; Piccinni, Carlo; Vergallo, Rocco; Montone, Rocco Antonio; Leone, Antonio Maria; Niccoli, Giampaolo; Sabatelli, Mario; Antonelli, Massimo; Andreotti, Felicita; De Cristofaro, Raimondo; Crea, Filippo-
92020Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisalGalli, M.; Andreotti, F.; D'Amario, D.; Vergallo, R.; Montone, R. A.; Niccoli, G.; Crea, F.-
102021Precision Phenomapping of Acute Coronary Syndromes to Improve Patient OutcomesAndreotti, Felicita; Iervolino, Adelaide; Navarese, Eliano Pio; Maggioni, Aldo Pietro; Crea, Filippo; Scambia, Giovanni-
112021Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trialsGalli, Mattia; Vescovo, Giovanni M; Andreotti, Felicita; D'Amario, Domenico; Leone, Antonio M; Benenati, Stefano; Vergallo, Rocco; Niccoli, Giampaolo; Trani, Carlo; Porto, Italo-
122021Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of STEMIGalli, Mattia; Migliaro, Stefano; Rodolico, Daniele; DI Stefano, Gaetano; Piccinni, Carlo; Restivo, Attilio; Andreotti, Felicita; Vergallo, Rocco; Montone, Rocco A; Besis, George; Buffon, Antonio; Romagnoli, Enrico; Aurigemma, Cristina; Leone, Antonio M; Burzotta, Francesco; Niccoli, Giampaolo; Trani, Carlo; Crea, Filippo; D'Amario, Domenico-
132021Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trialsBenenati, S.; Galli, M.; Marzo, V.; Pescetelli, F.; Toma, M.; Andreotti, F.; Bona, R. D.; Canepa, M.; Ameri, P.; Crea, F.; Porto, I.-
142021Methodological education in response to the quality of COVID-19 publicationsAndreotti, F.; Gervasoni, C.; Di Pasquale, G.; Maggioni, A. P.-
152021Prevalence, clinical impact and costs of hyperkalaemia: Special focus on heart failureMaggioni, A. P.; Dondi, L.; Andreotti, F.; Calabria, S.; Iacoviello, M.; Gorini, M.; Gonzini, L.; Piccinni, C.; Ronconi, G.; Martini, N.-
162021Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventionsGalli, M.; Capodanno, D.; Andreotti, F.; Crea, F.; Angiolillo, D. J.-
172021Sex- and gender‑specific precision medicine for chronic coronary syndromes: challenges and opportunitiesAndreotti, Felicita; Maggioni, Aldo P; Scambia, Giovanni-
182020Four-year trends in oral anticoagulant use and declining rates of ischemic stroke among 194,030 atrial fibrillation patients drawn from a sample of 12 million peopleMaggioni, A. P.; Dondi, L.; Andreotti, F.; Pedrini, A.; Calabria, S.; Ronconi, G.; Piccinni, C.; Martini, N.-
192020Coronary artery disease and type 2 diabetes: A proteomic studyFerrannini, G.; Manca, M. L.; Magnoni, M.; Andreotti, F.; Andreini, D.; Latini, R.; Maseri, A.; Maggioni, A. P.; Ostroff, R. M.; Williams, S. A.; Ferrannini, E.-
202020Lipoprotein(a) Reduction in Persons with Cardiovascular DiseaseAndreotti, Felicita; Maggioni, Aldo P-
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2022